Clinical Trial Update: ECALMIST Versus InSurE in Preterm Infant < 32 Weeks,Multicenter, Multinational RCT [NA]

View source ↗

Summary

Clinical trial update for a multicenter, multinational randomized study comparing ECALMIST with InSurE in preterm infants under 32 weeks with Respiratory Distre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• ECALMIST
• InSurE

Snippet

Sponsor: University of Manitoba | Conditions: Respiratory Distress Syndrome | NA | Status: UNKNOWN